Open Outcrier Sign Up/Sign In
Sign Up/Sign In

Open Outcrier is a news and chat platform geared toward options traders.


What's Inside

Open Outcrier Feed

Tons of trades and insights that are not posted to other socials.

The Pit

Real-time chat with other traders and the Open Outcrier folks themselves.

Full Search

Search through news articles, posts, and chat.

Custom Benzinga Feed

More in-depth than the free one on their site.

Daily Digest

Pre-market news sent straight to your inbox.

Sign Up Today

Free 2-week trial, no credit card required

Free Email Digest

$0/mo

  • Daily digest, delivered via email

Pro Platform Access

$99/mo

2 week free trial, no credit card required. One month free when you subscribe yearly.
  • Full access to the platform
  • Open Outcrier Feed
  • Real-time Chat
  • Custom Benzinga News Feed
  • Daily Email Digest
Try for Free

Compare Plans

Free Email Digest Pro Platform Access
Daily Email Digest Optional
Access to Open Outcrier Platform
Open Outcrier Feed
Real-time Chat with Other Traders
Custom Benzinga News Feed
Platform-spanning Cashtag Search
Try for Free

What We're Watching Today

Econ Calendar Mon 11/9/26Michelle Bowman Speaks 8:40 AM ETAustan Goolsbee Speaks 10:00 AM ETWholesale Inventories (Preliminary) 10:00 AM ET3&6-Month Bill Auction 11:30 AM ETThomas Barkin Speaks 12:15 PM ET6-Week Bill Auction 3-Yr Note Auction 1:00 PM ET
Wall St futures rise after rough week, but Nvidia unsettles investors - Reuters
Rubio sees little hope of diplomatic breakthrough to Mideast deadlock amid ‘outrageous’ Iranian demands - CNBC
Trump to meet Iran war mediator Qatar, no imminent deal seen to end the war - Reuters
Trump Says Strikes Unlikely as Rubio Slams Iran’s Demands - BBG
Oil Falls on Unconfirmed Report That Iran Eased Hormuz Demands - BBG
Congress returns with government funding, Pete Hegseth and the debt limit on the agenda - CNBC
Hegseth Impeachment Backed by Democratic Leader Jeffries - BBG
With Stephen Miller at the helm, Trump charts a course for conflict - Reuters
‘Trump has cost us’: After midterm losses, MAGA asks if it’s over - Reuters
Trump Says He Was Kidding About Hiring Dana White as Press Secretary - WSJ
The other Dana White responds to Trump’s surprise White House press secretary announcement
Five Takeaways From Trump’s ‘60 Minutes’ Interview - WSJ
After midterm rout, Vance tries to build his own 2028 brand - Reuters
Democrats Promised to Fix the Economy. What Can They Really Do? - WSJ
How Democrats will try to end Trump’s tariffs - CNBC
Democrats plan probes of Musk, Miller, corporate America after midterm rout - Reuters
US Congress gets first post-'Blue Wave' crack at data centers with permitting bill - Reuters
G7 allies to assess impact of Trump's midterm setback at Paris talks - Reuters
Trump’s Weakness and Overtures to Russia Put Ukraine on Edge - BBG
Hacked Records Show 400,000 Russians Killed in War on Ukraine - BBG
Fuel shortages return to Russian regions after Ukrainian refinery attacks - Reuters
German exports rise more than expected in September
French PM Lecornu holds talks over protesters' cost-of-living concerns
UK employers report weaker hiring but stronger pay growth in October
China Extends Pause on US Tariffs and Trade Curbs for Two Months - BBG
China’s Push for Influence in the South Pacific Is Running Into Resistance - WSJ
Trump thinks he will meet Xi and Putin at China APEC summit
Taiwan's October exports surge again on strong AI demand
Chinese banks boost dollar deposit rates, sources say, as Beijing seeks to smooth yuan rally
$NVDA (-5.2% pre) Nvidia Shares Drop After CEO Huang’s Affair Triggers Board Probe
$NVDA (-5.2% pre) Read Huang’s email to his staff and statement from Nvidia’s board of directors
$NVDA (-5.2% pre) Megaspeed exec was recruited to spy on Nvidia CEO, according to US intelligence memo
$GOOGL (+2.9% pre) Google to introduce two variants of in-house chips, Bloomberg News reports
$AKAM (-4.9% pre) Akamai Technologies Seeks $2.2 Billion From Convertible Bonds
$COIN (-1.8% pre) Coinbase Gets Final Regulatory Stamp for Trust-Bank Charter
$TSLA (+0.6% pre) Musk Says Tesla to Return Cybertruck Deposit to ‘Lot of People’
$GT (-3.4% pre) Goodyear Tire stock falls as CEO Mark Stewart exits abruptly
$SIRI (-1.7% pre) SiriusXM Eyes the Executive Behind Tubi's Explosive Growth As Its Next CEO
$GFR (+38.0% pre) Strathcona Resources to buy Greenfire Resources in cash-and-stock deal up to C$2.9B
$JBLU (+3.3% pre) CFO told employees the airline is not considering Chapter 11.
$NRG (+4.8% pre) NRG Energy to sell six power plants to LS Power for $4 billion
$GOOGL (+2.9% pre) Alphabet Mulls Asia Bond Sale as AI Fears Fuel Volatility
$DDI (+17.0% pre) DoubleU Games and DoubleDown Interactive Enter into Agreement for an All-Cash Tender Offer at US$16.25 per ADS
$YMAT (+19.0% pre) J-Star Holding Co., Ltd. Highlights U.S. Operational Progress with Delegation Visit from Global Tier 1 Carbon Fiber Manufacturer
$PLCE (-37.5% pre) Chapter 11 Filing Means The Children’s Place Fate Decided by Dec. 9
$NWGL (+46.6% pre) Changes in Registrant’s Certifying Accountant
$ARGX (+1.7% pre) argenx Phase 3 trial shows efgartigimod benefit in myositis
$ARGX (+1.7% pre) argenx to acquire Unnatural Products for up to $1.15 billion
$ARWR (-9.0% pre) Arrowhead drug cuts pancreatitis rate, shows dual lipid reductions
$CGEM (+6.1% pre) Cullinan Therapeutics (CGEM) Reports Positive Phase 1b/2a Data on Velinotamig for Refractory SLE
$CMPS (+4.5% pre) Compass Pathways files psilocybin drug application with FDA for depression
$HRTX (+41.4% pre) $CRMD CorMedix to acquire Heron Therapeutics assets for ~$222.6M
$CRMD (+4.3% pre) CorMedix stock gains as $HRTX Heron deal adds four products
$EDSA (+35.5% pre) Edesa Biotech licenses paridiprubart to Kyorin for Japan in $140M deal
$IBRX (-14.1% pre) IBRX: ImmunityBio Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
$IMMP (+8.1% pre) Immutep (IMMP) Reports Positive Phase I Data for IMP761 at ACR Convergence 2026
$MANE (+2.7% pre) Veradermics reports 12-month hair growth data for oral minoxidil drug
$MLYS (+6.4% pre) Mineralys Therapeutics (MLYS) Reports Promising Long-Term Data on Lorundrostat for Resistant Hypertension
$NKTX (-15.0% pre) Nkarta reports early trial data for autoimmune cell therapy
$REGN (+0.9% pre) Regeneron's CIDEBsiRNA cuts liver fat up to 80% in phase 1/2 trial
$VIR (+10.4% pre) Vir Biotechnology reports Phase 2 hepatitis delta drug data
$ZURA (-68.5% pre) Zura Bio's tibulizumab fails Phase 2 trial in skin disease
$SPCX (+2.4% pre) Elon Musk Says He's 'Excited' About $QCOM Qualcomm Deal As SpaceX Gears Up For Massive 5G Expansion
$CECO (+9.7% pre) CECO: Q3 growth, a $2.2B backlog, and stronger FY26 cash-flow guidance underpin the outlook
$CEG (+2.5% pre) Constellation Energy raises 2026 earnings guidance after quarterly profit more than doubles
$DCTH (+21.3% pre) Delcath Systems earnings beat by $0.26, revenue topped estimates
$IMVT (+10.5% pre) Immunovant, Inc. (IMVT) Tops Q2 EPS by 27c
$KKR (+1.3% pre) KKR posted record quarterly profit as fee-related earnings climbed 27%
$QXO (+8.3% pre) QXO reports preliminary Q3 net sales of $4.9 billion
$VFF (+5.2% pre) Village Farms International Reports Q3 2026 Results Driven by Record Cannabis Revenues
$ASST (-2.8% pre) Asset Entities Non-GAAP EPS of $5.46, revenue of $2.69M misses by $0.31M
$BRK/B (-0.2% pre) The biggest takeaway from Berkshire Hathaway’s latest quarter isn’t the $357 billion cash or its stock buybacks
$CEVA (-12.6% pre) CEVA Q3 non-GAAP Earnings, Revenue Rise; Shares Down
$DOLE (-4.2% pre) Dole shares drop as earnings miss, full-year target trimmed
$IONS (-18.8% pre) Ionis Slashes Key Drug Revenue Outlook by 50%, Overshadowing Otherwise Solid Earnings
$MNDY (-13.6% pre) Monday.com shares sink as weak guidance overshadows Q3 results
$OCUL (-8.3% pre) Ocular Therapeutix (OCUL) Q3 Revenue Misses Expectations Amid NDA Filing Plans for AXPAXLI
$SBET (-4.5% pre) SharpLink GamingEPS of $3.45, revenue of $13.46M beats by $0.5M
$SGI (-6.5% pre) Somnigroup International (SGI) Lags Q3 Earnings and Revenue Estimates
$SOC (-71.5% pre) Sable Offshore tumbles 75% as crude oil sales halted in October
$TPB (-19.2% pre) Turning Point Brands slides after heavy marketing investments impact profit (
Top Earnings Mon 11/9 Aft: $AAON $ABCL $ACHR $ALTG $ALTI $AMCX $AMRC $AMRO $APEI $APPS $ASTS $AVD $AVIR $BAP $BCSF $BETR $BKKT $BTGO $BW $CCAP $CHRS $CNCK $CNNE $CSQR $CWEN $CWST $DCGO $DFTX $DHT $DJT $DSP $EQPT $EQX $ETD $EXK $EXOD $FF $FWRD $GAIN $GMRS $GRPN $GSHD $HDRN $HFFG $HIMS $HIVE $HNRG $HPK $HRB $HROW $HYPR $IFS $IHRT $INR $JBS $JRVR $KLTR $KMPR $LCID $LFVN $LIF $LINE $LTRX $MARA $MDCX $MLAB $MNTK $MVST $MYO $NGS $NHI $NOVT $NRDY $ONTO $OPI $OSG $OSUR $OXBR $OXY $PAAI $PAYS $PII $PLUG $PPHC $PUBM $QLYS $QMCO $QUBT $RAIL $RKLB $RLGT $RNGR $RPAY $RXT $SANM $SB $SCM $SECZ $SENS $SIGA $SKYD $SMC $TDW $THRY $TRVI $TTD $TTEC $TTWO $URG $USAR $WBTN $WGS $XENE $ZETA $ZIP $ZYME
Top Earnings Tu 11/10 Pre: $ACCS $ALH $AMBQ $AP $ATAT $AUTL $AVNW $BRSL $BTDR $BWAY $CAN $CLRB $COAG $CWCO $ELMT $ETOR $GHI $GILT $HBIO $HMC $HSAI $HUMA $IMSR $JBI $JRSH $JSDA $KULR $LAR $LEGN $LNSR $LQDA $MASS $MCFT $MUX $NINE $ONON $PDYN $PLX $QBTS $REFI $SBH $SE $SRRK $TDG $TLSI $TONX $UONEK $VG $WIX $WYFI $XGN
$NTHI (+7.4% pre) NeOnc CEO buys 70,000 more shares for about $230,000
Upgrades 11/9: $ABNB $AMD $DNOW $IIPR $ROL $SNY $SOBO $TMCI $TRIP $TROX $UNM
Downgrades 11/9: $AMRZ $BETA $DKNG $FMS $IBP $LYFT $NVDA $NXH $PDD $TAP $TRU $ZG
+Initiations 11/9: $AMRO $BLSH $BROS $COAG $COPR $CWH $EPRX $GHM $IAM $IRON $KLRA $LHX $MTRI $PATK $PBLS $SBUX $SLDB $SUPN $UBER $UTHR
-Initiations 11/9: $WGO
$SMX (+18.7% pre) SMX Is Building a Verifiable Identity Layer for Fashion, From Cotton Fields to Luxury Resale
$ABEO (-12.5% pre) Abeona acquires EoE drug candidate, raises $30M in PIPE
Top Shareholder Meetings: $LSTA, $SAFX, $TPST
Top Analyst/Investor Calls: $AXGN, $ENTG, $FJET, $JANX, $MTD, $REFR, $RPM, $UMAC, $VIR
Top Conferences: o Adobe Max o American Academy of Optometry Conference o AASLD Meeting o BMO Financials Conference o Citi's FinTech Conference o DA Davidson Critical Minerals Conference o Guggenheim Healthcare Innovation Conference o Northcoast Research Fall Management o Raymond James Insurance Symposium o UBS Global Healthcare Conference o Wolfe Research Healthcare Conference